Prostate Cancer Therapeutics Laboratory

The Prostate Cancer Therapeutics Laboratory looks at the predictive and prognostic utility of circulating biomarkers in advanced prostate cancer. Current projects focus on androgen receptor splice variants (ARVs) and circulating tumour DNA (ctDNA).

To know more about us, click on the links below.